Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51
Japanese encephalitis virus (JEV) is the leading cause of viral encephalitis in Asia with a case fatality rate up to 35% and long-term sequelae up to 75%. This active-controlled, randomized, multi-centre, observer-blind, phase III trial investigated the neutralising antibody response to the new Japa...
Saved in:
Published in | Vaccine Vol. 26; no. 48; pp. 6151 - 6156 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Kidlington
Elsevier Ltd
11.11.2008
Elsevier Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!